Tumor lysis syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Tumor lysis syndrome}} {{CMG}} ==Overview== ==Risk Factors== Usually, the precipitating medication regimen includes combination chemotherapy, but those patient...") |
No edit summary |
||
Line 5: | Line 5: | ||
==Risk Factors== | ==Risk Factors== | ||
Usually, the precipitating medication regimen includes combination [[chemotherapy]], but those patients with lymphoma and ALL can be affected with [[steroid]] treatment alone. | Usually, the precipitating medication regimen includes combination [[chemotherapy]], but those patients with lymphoma and ALL can be affected with [[steroid]] treatment alone. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] |
Revision as of 14:57, 30 August 2015
Tumor lysis syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tumor lysis syndrome risk factors On the Web |
American Roentgen Ray Society Images of Tumor lysis syndrome risk factors |
Risk calculators and risk factors for Tumor lysis syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk Factors
Usually, the precipitating medication regimen includes combination chemotherapy, but those patients with lymphoma and ALL can be affected with steroid treatment alone.